Treatment for Diabetes

作者: Stephen J. Brand , Ronald V. Nardi , Indu Parikh , Anne Lane

DOI:

关键词:

摘要: Methods and compositions for treating diabetes mellitus in a patient need thereof are provided. The methods include administering to composition providing gastrin/CCK receptor ligand, e.g., gastrin, and/or an epidermal growth factor (EGF) TGF-α, amount sufficient effect differentiation of pancreatic islet precursor cells mature insulin-secreting cells. can be administered systemically or expressed situ by transgenically supplemented with one both ligand gene, preprogastrin peptide gene EGF TGF-α gene. also transplanting into cultured islets which beta proliferated exposure ligand.

参考文章(65)
William T. Phillips, Gary M. Green, Joyce G. Schwartz, Methods of normalizing metabolic parameters in diabetics ,(1993)
Suresh Rattan, Moustapha Kassem, Thomas Jensen, Immortalized stem cells ,(2002)
Brigid Hogan, Elizabeth Lacy, Frank Costantini, Manipulating the mouse embryo: A laboratory manual ,(1986)
Berent J. Prakken, Salvatore Albani, Stress proteins and peptides and methods of use thereof ,(2001)
Alistair J. Douglas, Brian Walker, Richard Finbar Murphy, Novel C-terminal gastrin antagonists ,(1989)
William F. Witcraft, Magnetic sensing device ,(2003)
Gregory P. Thill, Richard G. Buckholz, Robert S. Siegel, Lillian M. Wondrack, Production of epideramal growth factor in pichia pastoris yeast cells ,(1989)